Format

Send to

Choose Destination
Eur J Neurol. 2017 Aug;24(8):1055-1061. doi: 10.1111/ene.13334. Epub 2017 May 29.

Migraine associated with altitude: results from a population-based study in Nepal.

Author information

1
Department of Neuromedicine and Movement Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
2
Norwegian Advisory Unit on Headache, St Olavs University Hospital, Trondheim, Norway.
3
Institute of Clinical Sciences, Lund University, Lund, Sweden.
4
Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal.
5
Division of Brain Sciences, Imperial College London, London, UK.

Abstract

BACKGROUND AND PURPOSE:

A 1988 pilot study in Peru suggested an association between migraine and chronic exposure to high altitude. This study provides epidemiological evidence corroborating this.

METHODS:

In a cross-sectional nationwide population-based study, a representative sample of Nepali-speaking adults were recruited through stratified multistage cluster sampling. They were visited at home by trained interviewers using a culturally adapted questionnaire. The altitude of dwelling of each participant was recorded.

RESULTS:

Of 2100 participants, over half [1100 (52.4%)] were resident above 1000 m and almost one quarter [470 (22.4%)] at ≥2000 m. Age- and gender-standardized migraine prevalence increased from 27.9% to 45.5% with altitude between 0 and 2499 m and thereafter decreased to 37.9% at ≥2500 m. The likelihood of having migraine was greater (odds ratio, 1.5-2.2; P ≤ 0.007) at all higher altitudes compared with <500 m. In addition, all symptom indices increased with altitude across the range <500 m to 2000-2499 m, i.e. median attack frequency from 1.3 to 3.0 days/month (P < 0.001), median duration from 9 to 24 h (P < 0.001) and pain intensity [the proportion reporting 'bad pain' (highest intensity)] from 35.5% to 56.9% (P = 0.011). Each of these showed a downward trend above 2500 m.

CONCLUSIONS:

Dwelling at high altitudes increases not only migraine prevalence but also the severity of its symptoms.

KEYWORDS:

Global Campaign against Headache; altitude; epidemiology; headache; hypoxia; migraine; prevalence; risk factors

PMID:
28556384
PMCID:
PMC5518276
DOI:
10.1111/ene.13334
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center